Google’s latest investment in Anthropic fortifies its cloud ties to the startup’s Claude AI agents—the main adversary of Google’s Gemini chatbots.
The time-honored tradition of scouring a new cereal box in search of a prize is coming back to the breakfast…
To protect your company’s bottom line, you must treat it like P&L.
New research on tirzepatide, the drug behind Zepbound and Mounjaro, suggests it could significantly lower the risk of major cardiovascular…
The company’s new Mythos system can autonomously find and exploit software vulnerabilities, but at what cost?
